The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
OPEN The Lancet. Public health | 4 Jul 2020
J Hewitt, B Carter, A Vilches-Moraga, TJ Quinn, P Braude, A Verduri, L Pearce, M Stechman, R Short, A Price, JT Collins, E Bruce, A Einarsson, F Rickard, E Mitchell, M Holloway, J Hesford, F Barlow-Pay, E Clini, PK Myint, SJ Moug and K McCarthy
The COVID-19 pandemic has placed unprecedented strain on health-care systems. Frailty is being used in clinical decision making for patients with COVID-19, yet the prevalence and effect of frailty in people with COVID-19 is not known. In the COVID-19 in Older PEople (COPE) study we aimed to establish the prevalence of frailty in patients with COVID-19 who were admitted to hospital and investigate its association with mortality and duration of hospital stay.
* Data courtesy of Altmetric.com